Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

217.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 617,654
  • Market Cap: £471.78m
  • RiskGrade: 156

AMS Overview

We are a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on value for our customers and quality outcomes for patients.
Competitors: Convatec Group, Consort Medical
Registrars: Capita Registrars

Key Personnel

CEO: A Christopher (Chris) Meredith
CFO: Eddie Johnson
Chairman: Liz Shanahan
Independent Non-Executive Director: Douglas Le Fort
Senior Independent Non-Executive Director: Grahame Cook
Non-Executive Dir:

Contact Details

Address: Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, United Kingdom, CW7 3RT
Phone: +44 (0) 1606 863500
Fax: +44 (0) 1606 863600
Website: http://www.admedsol.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0004536594

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 217.00p
Change Today 1.00p
% Change 0.46 %
52 Week High 258.00
52 Week Low 177.20
Volume 617,654
Shares Issued 217.41m
Market Cap £471.78m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.26% below the market average74.26% below the market average74.26% below the market average74.26% below the market average74.26% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average
Price Trend
17.47% below the market average17.47% below the market average17.47% below the market average17.47% below the market average17.47% below the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average
Income
86.92% below the market average86.92% below the market average86.92% below the market average86.92% below the market average86.92% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Growth
37.2% below the market average37.2% below the market average37.2% below the market average37.2% below the market average37.2% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 31-May-2024

Time Volume / Share Price
16:44 1,197 @ 217.00p
16:35 250,167 @ 217.00p
16:35 1 @ 217.00p
16:35 435 @ 217.00p
16:35 1,137 @ 217.00p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page